181 related articles for article (PubMed ID: 33617666)
1. Cyclometalated Iridium(III) Complexes as Mitochondria-targeting Photosensitizers against Cisplatin-resistant Cells.
Xiong K; Zhou Y; Lin X; Kou J; Lin M; Guan R; Chen Y; Ji L; Chao H
Photochem Photobiol; 2022 Jan; 98(1):85-91. PubMed ID: 33617666
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
3. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
5. Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments.
He SF; Han WC; Shao YY; Zhang HB; Hong WX; Yang QH; Zhang YQ; He RR; Sun J
Bioorg Chem; 2023 Dec; 141():106867. PubMed ID: 37734195
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
[TBL] [Abstract][Full Text] [Related]
7. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
9. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
Xiong K; Chen Y; Ouyang C; Guan RL; Ji LN; Chao H
Biochimie; 2016 Jun; 125():186-94. PubMed ID: 27039888
[TBL] [Abstract][Full Text] [Related]
10. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
[TBL] [Abstract][Full Text] [Related]
11. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
12. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
14. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
[TBL] [Abstract][Full Text] [Related]
15. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
Li Y; Wang KN; He L; Ji LN; Mao ZW
J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
[TBL] [Abstract][Full Text] [Related]
17. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
18. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance.
Cao JJ; Zheng Y; Wu XW; Tan CP; Chen MH; Wu N; Ji LN; Mao ZW
J Med Chem; 2019 Apr; 62(7):3311-3322. PubMed ID: 30816710
[TBL] [Abstract][Full Text] [Related]
20. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
